Xeris Pharmaceuticals | XERS - 流动负债

金融业

USD

USD 392.01M

现金及等价物

USD 111.75M

USD 13.66M

USD 251.68M

USD 118.59M

USD 257.65M

USD 16.77M

USD 25.09M

377

EPS每股收益

USD 0.01

股本和储备

USD 13.01M

USD 72.15M

债务利息支出

USD 7.15M

USD 1.16M

USD 221.22M

USD 868M

USD 11.08M

USD 69.03M

USD 16.77M

普通股股本

USD 166.22M

2.45K

USD 11.08M

USD 83.13M

销售和管理费用

USD 42.64M

USD 74.23M

贸易债权人

USD 11.47M

应收帐款人

USD 51.05M

	流动负债	更改		日
Celltrion	KRW 283.62B		3.72T	2025-12
Cspc Pharmaceutical	CNY 10.18B		65.36M	2025-12
Deva Holding AS	TRY 6.43B		1.18B	2023-09
Dianthus Therapeutics	USD 38.28M		7.55M	2026-03
Divis Laboratories Ltd	INR 20.43B		3.15B	2026-03
Eli Lilly	USD 36.63B		1.41B	2026-03
Kangmei Pharma	CNY 5.38B		433.79M	2026-03
Knight Therapeutics	CAD 165.26M		12.58M	2025-12
Laboratorios Farma	EUR 199.84M		121.75M	2023-12
Malin Corporation	EUR 1000K		500K	2024-12
Medical Developments International	AUD 5.56M		2.26M	2025-12
Nektar Therapeutics	USD 53.54M		12.8M	2025-12
Neuren Pharmaceuticals	AUD 4.34M		3.58M	2025-12
Organigram Holdings	CAD 94.05M		32.11M	2025-12
Ovoca Bio	EUR 186K		2.26M	2025-06
Pacira	USD 108.79M		11.8M	2026-03
Perrigo	USD 997.6M		15.3M	2026-03
Pharma Mar	EUR 89.23M		4.65M	2026-03
Qiagen NV	USD 512.14M		461.26M	2025-12
Sartorius	EUR 2.11B		145.8M	2026-03
Sino Biopharmaceutical	CNY 24.85B		5.29B	2025-06
Supernus Pharmaceuticals	USD 373.93M		35.76M	2026-03
Tilray	USD 259.32M		8.32M	2025-09
Zealand Pharma A/S	664.96M		513.61M	2025-12
Zz Pientze Pharmaceu	CNY 2.28B		134.52M	2026-03